Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to -$2.4 million.

  • GoHealth's Cash from Investing Activities fell 11784.99% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.5 million, marking a year-over-year decrease of 285421.05%. This contributed to the annual value of $3.8 million for FY2024, which is 12772.36% up from last year.
  • Per GoHealth's latest filing, its Cash from Investing Activities stood at -$2.4 million for Q3 2025, which was down 11784.99% from -$2.8 million recorded in Q2 2025.
  • GoHealth's 5-year Cash from Investing Activities high stood at $13.3 million for Q3 2024, and its period low was -$11.4 million during Q3 2021.
  • In the last 5 years, GoHealth's Cash from Investing Activities had a median value of -$2.8 million in 2025 and averaged -$2.7 million.
  • Per our database at Business Quant, GoHealth's Cash from Investing Activities tumbled by 29865.82% in 2023 and then soared by 48759.85% in 2024.
  • GoHealth's Cash from Investing Activities (Quarter) stood at -$532000.0 in 2021, then plummeted by 166.17% to -$1.4 million in 2022, then tumbled by 298.66% to -$5.6 million in 2023, then surged by 60.71% to -$2.2 million in 2024, then dropped by 6.9% to -$2.4 million in 2025.
  • Its Cash from Investing Activities stands at -$2.4 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$3.0 million for Q1 2025.